|
SESN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.733600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.472000E-01 |
| Normal-vs-Stage2 |
2.982000E-01 |
| Normal-vs-Stage3 |
7.319600E-01 |
| Normal-vs-Stage4 |
2.297400E-03 |
| Stage1-vs-Stage2 |
3.650000E-01 |
| Stage1-vs-Stage3 |
6.210200E-01 |
| Stage1-vs-Stage4 |
4.074000E-02 |
| Stage2-vs-Stage3 |
6.776200E-01 |
| Stage2-vs-Stage4 |
1.860810E-01 |
| Stage3-vs-Stage4 |
7.494400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.789600E-01 |
| Normal-vs-AfricanAmerican |
6.868400E-01 |
| Normal-vs-Asian |
2.920300E-03 |
| Caucasian-vs-AfricanAmerican |
6.016400E-01 |
| Caucasian-vs-Asian |
1.975030E-04 |
| AfricanAmerican-vs-Asian |
1.389400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.218000E-03 |
| Normal-vs-Female |
1.053010E-01 |
| Male-vs-Female |
2.729900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.809000E-01 |
| Normal-vs-Extreme_Weight |
3.025800E-01 |
| Normal-vs-Obese |
4.240600E-01 |
| Normal-vs-Extreme_Obese |
1.855950E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.522600E-01 |
| Normal_Weight-vs-Obese |
4.000000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.216800E-01 |
| Extreme_Weight-vs-Obese |
6.849200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.105200E-01 |
| Obese-vs-Extreme_Obese |
2.473800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.954400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.172800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.312310E-02 |
| Normal-vs-Age(81-100Yrs) |
4.182600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.296000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.229200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.825600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.173700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.918240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.446800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.282800E-01 |
| Normal-VS-Type2 PRCC |
8.283600E-01 |
| Normal-VS-KIRP CIMP |
7.202200E-01 |
| Normal-VS-Unclassified PRCC |
2.967600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.155200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.653000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.171700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.946400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.853200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.513200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.018400E-02 |
| Normal-vs-N1 |
2.733400E-01 |
| Normal-vs-N2 |
6.062100E-02 |
| N0-vs-N1 |
7.195600E-01 |
| N0-vs-N2 |
6.287400E-01 |
| N1-vs-N2 |
5.838400E-01 |
|
|
